Author

Dirk C. Davidson

Observed name: Dirk Davidson

Observed institutions: Memorial Sloan Kettering Cancer Center, Yale Cancer Center

OpenAlex ID: A5109877535

The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care

2012 · Linda Bosserman, Franklyn Prendergast, et al. · Cancer Research · 19

Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer

2015 · Linda Bosserman, Karl Rogers, et al. · PLoS ONE · 12

Correlation of drug‐induced apoptosis assay results with oncologist treatment decisions and patient response and survival

2012 · Linda D. Bosserman, Swapnil P. Rajurkar, et al. · Cancer · 12

PersonalizedCancer Care: A New Paradigm in Oncology

2010 · Cary A. Presant, Pat Whitworth, et al. · Oncology Issues · 1

Are generic multisource (generic) chemotherapy (CT) drugs as effective as proprietary single-source (proprietary) drugs: Evidence from in vitro CT-induced apoptosis (APOP) in non-small cell lung cancer (NSCLC), colorectal cancer (Colon CA) compared to recurrent/metastatic breast carcinoma (Breast CA).

2012 · Misagh Karimi, Swapnil Padmakar Rajurkar, et al. · Journal of Clinical Oncology

Patterns of in vitro chemotherapy (CT)-induced apoptosis (APOP) in recurrent/metastatic breast carcinoma (CA): Comparisons of generic multisource drugs (generics) with proprietary single-source drugs (proprietaries).

2012 · Linda D. Bosserman, Karl Rogers, et al. · Journal of Clinical Oncology

Four steps to improve the profitability of your oncology practice

2009 · Dirk Davidson

Works count: 7

Citation count: 44

H-index: 3

I10-index: 3